Skip to main content

Animations

MJFF Publications

3361 - 3370 of 8801 Results
Title
Year
  • Year
  • 2018
  • 2025
  • 2025
  • 2025
  • 2022
  • 2023
  • 2025
  • 2017
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2018.11.002
    Citation Count: 36
  • Summary Details
    RESTRICTED
    Title: Frailty in prodromal Parkinson's disease in Medicare beneficiaries
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107965
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaques
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-00938-9
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Hope vs. Hype I: It is time to redefine and rename Parkinson disease based on alpha-synuclein
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107983
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.838674
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Targeting LRRK2 mRNA stability in Parkinson’s disease
    Journal Name: Trends in Neurosciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.tins.2023.10.003
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Use of β-adrenoreceptor drugs and Parkinson’s disease incidence in women from the French E3N cohort study
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x251330993
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Decision-Making Deficits Associated with Amyloidosis in Lewy Body Disorders
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2016.00693
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson’s disease
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-020-02224-9
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease
    Journal Name: Psychogeriatrics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/psyg.12601
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.